文献速递其他结缔组织病

特发性炎症性肌病诊断前后整体及部位特异性癌症风险:2002-2016年全国性研究

Overall and site-specific cancer before and after diagnosis of idiopathic inflammatory myopathies: A nationwide study 2002-2016.
PubMed 文献 · Semin Arthritis Rheum · 2020-12-24

该研究基于瑞典全国登记数据,纳入1419例特发性炎症性肌病(IIM)患者和7045名一般人群对照,采用病例对照和队列设计分别评估IIM诊断前和诊断后癌症发生风险。结果显示,IIM诊断前整体癌症风险升高(AOR 1.5,95%CI 1.3-1.8),诊断后亦升高(AHR 1.7,95%CI 1.4-2.0),且诊断前后关联的癌症类型不同。

要点

  • IIM诊断前整体癌症风险升高,AOR 1.5(95%CI 1.3-1.8)。
  • IIM诊断后整体癌症风险升高,AHR 1.7(95%CI 1.4-2.0)。
  • 诊断前后关联的癌症类型不同,可能影响筛查决策。

核心结论

  • IIM诊断前后整体癌症风险均升高,但诊断前与诊断后关联的癌症类型不同,可能影响IIM的筛查决策。

研究设计与样本

  • 基于瑞典全国前瞻性登记数据,采用病例对照研究调查IIM诊断前癌症发生,采用队列研究调查IIM诊断后癌症发生。
  • 纳入2002-2016年瑞典诊断的1419例IIM患者,与7045名一般人群个体进行比较。
  • 分别通过逻辑回归和Cox回归模型估计IIM诊断前后癌症与IIM的关联。

主要发现

  • IIM诊断前整体癌症比值比升高,调整比值比(AOR)1.5(95%CI 1.3-1.8)。
  • IIM诊断后整体癌症风险升高,调整风险比(AHR)1.7(95%CI 1.4-2.0),相当于每年每125例IIM患者中额外发生1例癌症。
  • 诊断前与IIM关联的癌症包括结直肠癌(AOR 2.1)、肺癌(AOR 5.4)和卵巢癌(AOR 7.0)。
  • 诊断后与IIM关联的癌症包括口咽癌(AHR 9.1)、宫颈癌(AHR 3.8)、恶性黑色素瘤(AHR 3.2)和非黑色素瘤皮肤癌(AHR 3.1)。
  • 腺癌与诊断前皮肌炎相关,鳞状细胞癌与诊断后IIM相关;淋巴造血系统癌症与诊断前后IIM均相关。

临床怎么用

  • 对于IIM患者,应关注诊断前后不同癌症类型的风险,诊断前重点筛查结直肠癌、肺癌和卵巢癌,诊断后关注口咽癌、宫颈癌、黑色素瘤及非黑色素瘤皮肤癌。
  • 淋巴造血系统癌症在IIM诊断前后风险均升高,需予以重视。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the association between idiopathic inflammatory myopathy (IIM) and cancer before and after IIM diagnosis. METHODS: We used prospectively collected nationwide register data to design a case-control study to investigate the occurrence of cancer before IIM, and a cohort study to investigate the occurrence of cancer after IIM. Patients diagnosed with IIM between 2002 and 2016 in Sweden, were compared to the general population. The association between cancer and IIM was estimated before and after IIM diagnosis via logistic regression and Cox regression models, respectively. RESULTS: We included 1419 patients with IIM and 7045 individuals from the general population. The overall odds of cancer before IIM diagnosis were increased in IIM compared to the general population, adjusted odds ratio (AOR) 1.5, 95% confidence interval (CI) 1.3-1.8. This association was also noted after IIM diagnosis, adjusted hazard ratio (AHR) 1.7 (95% CI 1.4-2.0), or one additional cancer in every 125 IIM patients per year. Colorectal (AOR 2.1), lung (AOR 5.4) and ovarian (AOR 7.0) cancers were associated with IIM before diagnosis. Oropharyngeal (AHR 9.1) and cervical (AHR 3.8) cancers, malignant melanoma (AHR 3.2) and non-melanoma skin cancer (AHR 3.1) were associated with IIM after diagnosis. Adenocarcinomas were associated with dermatomyositis before diagnosis and squamous cell cancers after IIM diagnosis. Lymphatic hematopoietic cancers were associated with IIM both before and after diagnosis. CONCLUSIONS: The cancer types that occur before IIM diagnosis differ from the ones that occur after diagnosis. This may have an impact on screening decisions for IIM.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Dani L, Ian Che W, Lundberg IE, et al. Overall and site-specific cancer before and after diagnosis of idiopathic inflammatory myopathies: A nationwide study 2002-2016. Semin Arthritis Rheum. 2020. PMID: 33508731. doi:10.1016/j.semarthrit.2020.12.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。